# BioCheck acquires DRG International

BioCheck, Inc. announced the acquisition of DRG International, a manufacturer of clinical diagnostic and research ELISAs, on August 18, 2021. The deal expands BioCheck's IVD development and sales channels.

- Type: Acquisition
- Announced: 2021-08-18
- Where: United States
- Status: completed
- Products: ELISA kits, chemiluminescent immunoassay platforms, automated analyzers
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [BioCheck](https://endata.com/companies/57178.md) (acquirer)
- [DRG International](https://endata.com/companies/57179.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/biocheck-inc-acquires-drg-international-inc-a-leading-ivd-company), 2021-08-18: "the DRG:HYBRiD-XL® and BioCheck's new automated chemiluminescent platform (ACL-Platform) will enable us to accelerate the availability of optimized, reliable and accurate advanced clinical and research diagnostic tests"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.